| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.6 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.6 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.049 | 0.6 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.6 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | -0.031 | 0.6 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |